PTC Therapeutics (NASDAQ:PTCT) reported quarterly earnings results on February 19, 2026 that fell short of analyst expectations. The Healthcare company reported earnings per share…
PTC Therapeutics (NASDAQ:PTCT) reported quarterly earnings results on February 19, 2026 that fell short of analyst expectations.
The Healthcare company reported earnings per share of $-1.67, missing the consensus estimate of $-0.33 by $1.34 per share. Revenue came in at $164.7M, missing the estimate of $295.4M.
PTC Therapeutics's stock moved following the earnings release. The stock currently trades at $68.73 with a market capitalization of $6.1B.
Current market data
NASDAQ · PTCT
$71.79
Down: -$0.39 · -0.54%
Live quote updated
Our Markets Team monitors market data, SEC filings, analyst actions, earnings releases, and corporate announcements to produce timely updates for investors.
Keep reading
analyst ·
analyst ·
earnings ·
analyst ·
